Skip to main content
Lotus Pharm logo

Lotus Pharm — Investor Relations & Filings

Ticker · 1795 ISIN · TW0001795003 LEI · 984500BEECDBC04KP716 TW Manufacturing
Open in API
Filings indexed 2,730 across all filing types
Latest filing 2024-08-09 Regulatory Filings
Country TW Taiwan
Listing TW 1795

About Lotus Pharm

http://www.lotuspharm.com.tw

Lotus Pharmaceutical Co., Ltd. is a global specialty organization focused on the development, manufacturing, and commercialization of high-barrier generic and specialty medicines. The company specializes in complex generics, with a primary focus on oncology, immunology, and addiction treatment. Its portfolio includes technically demanding products such as Lenalidomide, Suboxone, Nintedanib, and Vinorelbine, as well as an advancing pipeline of biosimilars and 505(b)(2) oncology candidates. Utilizing an integrated R&D and manufacturing platform, the company executes a "2x2" growth strategy centered on dual market expansion and product diversification. Its commercial footprint spans over 90 markets globally, maintaining a strong presence in the Asia-Pacific region and the United States. The company prioritizes high technical entry barriers and cost-effective therapeutic solutions to improve global patient access to essential medications.

Recent filings

Filing Released Lang Actions
本公司受邀參加凱基證券舉辦之英文線上法人說明會
Regulatory Filings Classification · 90% confidence The document is a short announcement about the company (1795 美時) participating in an online investor presentation organized by KGI Securities. It includes details such as the date, time, and location of the event, and a link for registration. There is no financial data or detailed report content included. The document is under 5,000 characters and serves as a notice of an upcoming investor presentation rather than the presentation itself or a financial report. Therefore, it fits the category of Investor Presentation (IP) announcement, but since it is only an announcement and not the presentation material itself, it is best classified as Regulatory Filings (RNS) as a fallback for such announcements that do not contain the actual presentation content.
2024-08-09 Chinese
本公司將召開線上法人說明會
Investor Presentation Classification · 95% confidence The document is a short announcement (618 characters) about the company scheduling an online investor presentation (法人說明會) to discuss the Q2 financial and operational status. It specifies the date, time, and format of the event but does not contain any financial data or detailed report content. It is clearly an announcement of an upcoming investor presentation rather than the presentation itself or a financial report. Therefore, the appropriate classification is Investor Presentation (IP). Confidence is high given the explicit mention of a scheduled investor presentation.
2024-08-09 Chinese
113年7月背書保證與資金貸與
Regulatory Filings Classification · 95% confidence The document is a brief financial disclosure from a listed company, 美時, providing information on fund loans and endorsement guarantees for the current and previous month, including limits and balances. It is very short (613 characters) and contains tabular data on financial exposures but does not include comprehensive financial statements or detailed analysis. It appears to be a regulatory disclosure related to financial guarantees and loans rather than a full financial report or announcement of a meeting or vote. Given the nature and length, it fits best as a Regulatory Filing (RNS), which is a fallback category for miscellaneous regulatory disclosures that do not fit other specific categories.
2024-08-09 Chinese
113年7月營業收入
Fund Information / Factsheet Classification · 90% confidence The document is a financial summary report showing monthly and cumulative net operating revenue figures for a company named 美時 (Mei Shi) for the period of July 2024 (民國113年07月). It includes comparative figures from the previous year and percentage changes. The document is very short (779 characters) and primarily presents summarized financial data without detailed financial statements or analysis. It does not contain a full annual or interim report, nor does it include management discussion or audit information. It appears to be a brief financial factsheet or summary of key financial metrics. Given the length and content, it fits best as a Fund Information / Factsheet (FS) type document, which is a brief summary of key company facts and financials.
2024-08-09 Chinese
113年第2季權益變動表
Interim / Quarterly Report Classification · 95% confidence The document contains detailed financial tables showing changes in equity for the current and previous half-year periods (民國113年上半年度 and 民國112年上半年度), including items such as common stock, capital surplus, legal surplus reserve, special surplus reserve, undistributed earnings, retained earnings, and other equity components. The presence of comprehensive financial data for a half-year period indicates this is a substantive financial report rather than a brief announcement or certification. The document length is 4452 characters, which is sufficient for a detailed interim report. The content aligns with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes actual financial statements and analysis. There is no indication that this is an Annual Report (10-K), Earnings Release (ER), or other categories. Therefore, the classification is IR with high confidence. H1 2024
2024-08-08 Chinese
113年第2季現金流量表
Interim / Quarterly Report Classification · 95% confidence The document contains a consolidated cash flow statement for the second quarter of the 113th year (which corresponds to 2024) and compares it with the previous year. It includes detailed financial data such as cash flows from operating, investing, and financing activities. The presence of actual financial figures and the coverage of a period shorter than a full fiscal year indicate this is a quarterly or interim financial report. The document length is 2881 characters, which is relatively short but contains substantive financial data, so it is not merely an announcement or certification. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). H1 2024
2024-08-08 Chinese

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.